ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 15)

H-INDEX

(FIVE YEARS 0)

Published By American Chemical Society

9780841298644, 9780841298637

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Title, Copyright, Foreword

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.fw001 ◽

2020 ◽

pp. i-v

Download Full-text

Preface

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.pr001 ◽

2020 ◽

pp. ix-xiii

Author(s):

Jaan A. Pesti ◽

Ahmed F. Abdel-Magid ◽

Rajappa Vaidyanathan

Download Full-text

The Discovery and Chemical Development of BMS-919373: A Selective I Kur Inhibitor for the Potential Treatment of Atrial Fibrillation

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch002 ◽

2020 ◽

pp. 43-97

Author(s):

Heather J. Finlay ◽

Scott A. Savage ◽

Jason M. Stevens ◽

Steven R. Wisniewski ◽

Miao Yu

Keyword(s):

Atrial Fibrillation ◽

Potential Treatment

Download Full-text

Identification and Development of AMG 986: A Potent and Efficacious APJ Agonist for the Treatment of Heart Failure

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch004 ◽

2020 ◽

pp. 127-155

Author(s):

Matthew R. Kaller ◽

Paul Dransfield ◽

Robert P. Farrell ◽

Ted C. Judd

Keyword(s):

Heart Failure

Download Full-text

Discovery and Commercial Development of Cholesteryl Transfer Protein Inhibitor Evacetrapib

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch011 ◽

2020 ◽

pp. 339-372

Author(s):

Nathan B. Mantlo ◽

Scott A. Frank

Keyword(s):

Protein Inhibitor ◽

Commercial Development ◽

Transfer Protein

Download Full-text

Discovery and Process Development of BIIB068: A Reversible Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Autoimmune Diseases

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch010 ◽

2020 ◽

pp. 313-337

Author(s):

Bin Ma ◽

Chaomin Li ◽

Brian T. Hopkins ◽

Lloyd Franklin ◽

Robbie Chen ◽

...

Keyword(s):

Tyrosine Kinase ◽

Autoimmune Diseases ◽

Process Development ◽

Bruton’S Tyrosine Kinase ◽

Bruton's Tyrosine Kinase ◽

Btk Inhibitor

Download Full-text

Melflufen: A Journey from Discovery to Multi-Kilogram Production

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch005 ◽

2020 ◽

pp. 157-177

Author(s):

Fredrik Lehmann ◽

Johan Wennerberg

Download Full-text

Discovery and Chemical Development of the Use-Dependent Sodium Channel Blocker Vixotrigine for the Treatment of Pain

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch001 ◽

2020 ◽

pp. 1-42

Author(s):

David R. Witty ◽

David T. MacPherson ◽

Gerard M. P. Giblin ◽

Michael T. Williams ◽

Robbie Chen ◽

...

Keyword(s):

Sodium Channel ◽

Channel Blocker ◽

Sodium Channel Blocker

Download Full-text

Discovery and Chemical Development of Grazoprevir: An HCV NS3/4a Protease Inhibitor for the Treatment of the Hepatitis C Virus Infection

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch009 ◽

2020 ◽

pp. 285-312

Author(s):

Feng Xu ◽

John A. McCauley

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Protease Inhibitor ◽

Hepatitis C Virus Infection

Download Full-text

Discovery and Chemical Development of Relebactam: A Potent β-Lactamase Inhibitor in Combination with Primaxin® for the Treatment of Serious and Antibiotic-Resistant Bacterial Infections

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3 ◽

10.1021/bk-2020-1369.ch008 ◽

2020 ◽

pp. 253-284

Author(s):

Feng Xu ◽

Benjamin D. Sherry ◽

Timothy A. Blizzard

Keyword(s):

Bacterial Infections ◽

Antibiotic Resistant ◽

Lactamase Inhibitor

Download Full-text

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By American Chemical Society

Title, Copyright, Foreword

Preface

The Discovery and Chemical Development of BMS-919373: A Selective I Kur Inhibitor for the Potential Treatment of Atrial Fibrillation

Identification and Development of AMG 986: A Potent and Efficacious APJ Agonist for the Treatment of Heart Failure

Discovery and Commercial Development of Cholesteryl Transfer Protein Inhibitor Evacetrapib

Discovery and Process Development of BIIB068: A Reversible Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Autoimmune Diseases

Melflufen: A Journey from Discovery to Multi-Kilogram Production

Discovery and Chemical Development of the Use-Dependent Sodium Channel Blocker Vixotrigine for the Treatment of Pain

Discovery and Chemical Development of Grazoprevir: An HCV NS3/4a Protease Inhibitor for the Treatment of the Hepatitis C Virus Infection

Discovery and Chemical Development of Relebactam: A Potent β-Lactamase Inhibitor in Combination with Primaxin® for the Treatment of Serious and Antibiotic-Resistant Bacterial Infections

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 3
Latest Publications